InvestorsHub Logo
Followers 480
Posts 60094
Boards Moderated 18
Alias Born 09/20/2001

Re: ok2buy post# 9

Friday, 10/01/2021 8:46:44 PM

Friday, October 01, 2021 8:46:44 PM

Post# of 18
Trying to figure out why the stock dumped after this PR:


Dicerna Reports Positive Top-Line Results From PHYOX™2 Pivotal Clinical Trial of Nedosiran for the Treatment of Primary Hyperoxaluria
Aug 05, 2021


– Nedosiran Achieved Primary Endpoint, Demonstrating Statistically and Clinically Significant Sustained Reduction in Urinary Oxalate Excretion; Key Secondary Endpoint Also Achieved; Robust Efficacy Seen in PH1 Participants

more...



https://investors.dicerna.com/news-releases/news-release-details/dicerna-reports-positive-top-line-results-phyoxtm2-pivotal